The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Elaine M. Sloand

Hematology Branch

National Heart

Lung, and Blood Institute

Bldg 10 CRC 4-5230

USA

[email]@nhlbi.nih.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Hematology Branch, National Heart, Lung, and Blood Institute, Bldg 10 CRC 4-5230, USA. 2010
  • National Heart Lung and Blood Institute, Bethesda, MD 20892, USA. 2002 - 2010
  • National Heart Lung and Blood Institute, Hematology Branch, Office of Biostatistics Research, Division of Prevention and Population Sciences, USA. 2008
  • National Heart, Lung and Blood Institute, Division of Intramural Research, Hematology Branch, USA. 2008

References

  1. Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions. Sloand, E.M., Olnes, M.J., Shenoy, A., Weinstein, B., Boss, C., Loeliger, K., Wu, C.O., More, K., Barrett, A.J., Scheinberg, P., Young, N.S. J. Clin. Oncol. (2010) [Pubmed]
  2. Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success. Sloand, E.M., Barrett, A.J. Hematol. Oncol. Clin. North Am. (2010) [Pubmed]
  3. Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients. Sloand, E.M., Pfannes, L., Scheinberg, P., More, K., Wu, C.O., Horne, M., Young, N.S. Exp. Hematol. (2008) [Pubmed]
  4. Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. Sloand, E.M., Wu, C.O., Greenberg, P., Young, N., Barrett, J. J. Clin. Oncol. (2008) [Pubmed]
  5. CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins. Sloand, E.M., Pfannes, L., Chen, G., Shah, S., Solomou, E.E., Barrett, J., Young, N.S. Blood (2007) [Pubmed]
  6. Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria. Sloand, E.M., Mainwaring, L., Keyvanfar, K., Chen, J., Maciejewski, J., Klein, H.G., Young, N.S. Blood (2004) [Pubmed]
  7. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities. Sloand, E.M., Kim, S., Fuhrer, M., Risitano, A.M., Nakamura, R., Maciejewski, J.P., Barrett, A.J., Young, N.S. Blood (2002) [Pubmed]
 
WikiGenes - Universities